Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis
Dietary model of steatohepatitis was established by feeding mice a methionine choline deficient (MCD) diet. Mice on MCD or control diet for 3 weeks were treated with or without NO-1886, a newly synthetic lipoprotein lipase (LPL) activator. In a separate experiment, NO-1886 was given after pre-treatment with 3 weeks of MCD diet. NO-1886 significantly reduced MCD-induced inflammation by repressing levels of hepatic lipid peroxides and pro-inflammatory tumor necrosis factor-alpha (TNF-α),...[Show more]
|Collections||ANU Research Publications|
|Source:||Biochemical and Biophysical Research Communications|
|01_Yu_Lipoprotein_lipase_activator_2007.PDF||2.18 MB||Unknown||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.